Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 19, 2021

SELL
$221.91 - $258.6 $56,808 - $66,201
-256 Closed
0 $0
Q4 2020

Mar 09, 2021

BUY
$216.38 - $257.67 $55,393 - $65,963
256 New
256 $59,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tru Independence Asset Management 2, LLC Portfolio

Follow Tru Independence Asset Management 2, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tru Independence Asset Management 2, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tru Independence Asset Management 2, LLC with notifications on news.